A View LCS vs HealthCCSng
AI Verdict
Choose A View LCS if…
Choose A View LCS if your clinical workflow requires a comprehensive, multi-disease assessment of the thoracic cavity from a single low-dose CT scan. This tool is ideal for programs focused on integrated lung cancer screening that also benefit from simultaneous quantification of emphysema and coronary artery calcification to provide a holistic patient risk profile.
View A View LCS →Choose HealthCCSng if…
Choose HealthCCSng if your primary objective is to efficiently identify and quantify coronary artery disease risk by analyzing coronary artery calcification from routine, non-gated chest CT scans. This solution is best suited for integrating automated CAC scoring into existing workflows to leverage incidental findings for cardiovascular risk stratification without requiring additional specialized thoracic analyses.
View HealthCCSng →When choosing between AVIEW LCS and HealthCCSng, physicians should consider their primary diagnostic focus and workflow integration needs. AVIEW LCS excels in comprehensive thoracic CT analysis, offering a broad suite of features for lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. Its strengths lie in automated lung nodule detection and classification, Lung-RADS scoring, and detailed emphysema analysis, alongside CAC scoring and coronary artery segmentation. This makes it particularly well-suited for pulmonologists and radiologists managing a diverse range of thoracic conditions.
In contrast, HealthCCSng specializes in the automated detection and quantification of coronary artery calcification from routine CT scans. Its core strength is its ability to analyze non-contrast, non-ECG gated chest CTs to identify patients at risk of coronary artery disease, categorizing studies into CAC risk levels and generating numerical calcium scores. The key practical difference is AVIEW LCS’s broader thoracic diagnostic capabilities versus HealthCCSng’s focused, streamlined approach to CAC assessment. Physicians whose practice primarily involves comprehensive thoracic imaging and lung cancer screening will likely find AVIEW LCS more beneficial due to its extensive feature set. Conversely, cardiologists or radiologists primarily focused on efficient and automated coronary artery disease risk assessment from existing CT scans, with seamless PACS and EMR integration, would find HealthCCSng to be a more targeted and efficient solution.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | A View LCS | HealthCCSng |
|---|---|---|
| Pricing | Contact for quote | Not publicly available |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | Cloud-based, integrates with PACS and EMR systems |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HealthCCSngBoth tools emphasize automation and integration into existing clinical workflows. However, HealthCCSng explicitly highlights 'seamless integration with PACS and EMR systems' and an 'automated workflow for results without human intervention'. Its recent updates also include customizable CAC category configurations and numerical scoring, offering refined control for clinicians.
Clinical Value
A View LCSA View LCS offers a broader clinical value by providing comprehensive thoracic CT analysis, including automated lung nodule detection and classification (Lung-RADS), emphysema quantification, and detailed coronary artery calcification (CAC) scoring, all from a single low-dose CT scan. This '3-in-1 solution' addresses multiple critical thoracic diseases, offering a more holistic assessment compared to HealthCCSng's specialized focus on CAC.
Pricing & Value
HealthCCSngNeither tool provides public pricing. However, HealthCCSng has established a reimbursement pathway through a Category III CPT code (0721T & 0722T). This provides a clear mechanism for healthcare providers to financially leverage the solution, with studies indicating it can drive significant revenue and increase detection of cardiac risk.
Enterprise Readiness
A View LCSBoth tools are FDA-cleared and HIPAA compliant, establishing a baseline for enterprise readiness. A View LCS, however, offers more diverse deployment options including cloud-based, hybrid, local on dedicated hardware, and locally virtualized solutions. This flexibility allows it to adapt to a wider range of enterprise IT infrastructures and security requirements.
Innovation
A View LCSWhile both utilize AI for medical imaging, A View LCS demonstrates greater innovation through its comprehensive multi-disease analysis from a single low-dose CT scan, covering lung cancer screening, emphysema, and coronary artery calcification. Its 'CT kernel conversion AI technology' also highlights advanced image processing capabilities. HealthCCSng's innovation is significant in opportunistic CAC detection, but A View LCS's integrated approach is broader.
Support & Docs
A View LCSCoreline Soft, the company behind A View LCS, provides clear contact information for customer service, including dedicated email addresses and phone numbers for various departments and regional offices. The company also prominently features numerous publications and research, which serve as valuable documentation for clinical understanding and validation. HealthCCSng lacks specific public details regarding its support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | A View LCS | HealthCCSng |
|---|---|---|
| Tool Name | A View LCS | HealthCCSng |
| Company | Coreline Soft Co. | Nano-X AI |
| Primary AI Focus | Cardiology AI, Oncology AI, Radiology & Imaging AI (comprehensive thoracic CT analysis) | Cardiology AI (coronary artery disease) |
| Coronary Artery Calcification (CAC) Analysis | Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass), Segmentation of major coronary arteries | Automatically detects and quantifies coronary artery calcification (CAC), Categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, Generates a numerical calcium score, Provides visualization of calcified plaques within coronary arteries |
| Lung Nodule Detection | Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting | Not specified |
| Emphysema Analysis | Emphysema analysis and quantification (LAA) | Not specified |
Videos
Demos, reviews, and walkthroughs featuring A View LCS and HealthCCSng.